Literature DB >> 12686413

Successful treatment of radiation-induced brain necrosis by hyperbaric oxygen therapy.

Kiyotaka Kohshi1, Hajime Imada, Satoshi Nomoto, Raizoh Yamaguchi, Haruhiko Abe, Haruaki Yamamoto.   

Abstract

We describe a 68-year-old man who underwent hyperbaric oxygen (HBO) therapy to manage radiation necrosis of the brain, which developed after two treatments with stereotactic radiosurgery (SRS) to the same lesion. The necrosis was subsequently treated with steroids alone for 2 months; however, he progressed clinically and radiographically. Improvement again was noted with the reinstitution of HBO therapy. This case suggests that HBO therapy is an important therapeutic option in the treatment of brain radiation necrosis caused by SRS.

Entities:  

Mesh：

Year:  2003        PMID： 12686413     DOI： 10.1016/s0022-510x(03)00007-8

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


  18 in total

Review 1.  Bevacizumab for radiation necrosis following treatment of high grade glioma: a systematic review of the literature.

Authors:  Daniel Lubelski; Kalil G Abdullah; Robert J Weil; Nicholas F Marko
Journal:  J Neurooncol       Date:  2013-09-05       Impact factor: 4.130

2.  Double trouble: a tale of two radio-treatments.

Authors:  Ebere Sunny Ogbonnaya; Nikolay Peev; Sanjoy Nagaraja; Ronan Dardis
Journal:  BMJ Case Rep       Date:  2014-09-19

3.  Bevacizumab treatment leads to observable morphological and metabolic changes in brain radiation necrosis.

Authors:  Shingo Yonezawa; Kazuhiro Miwa; Jun Shinoda; Yuichi Nomura; Yoshitaka Asano; Noriyuki Nakayama; Naoyuki Ohe; Hirohito Yano; Toru Iwama
Journal:  J Neurooncol       Date:  2014-05-01       Impact factor: 4.130

4.  Dynamic contrast-enhanced perfusion processing for neuroradiologists: model-dependent analysis may not be necessary for determining recurrent high-grade glioma versus treatment effect.

Authors:  J D Hamilton; J Lin; C Ison; N E Leeds; E F Jackson; G N Fuller; L Ketonen; A J Kumar
Journal:  AJNR Am J Neuroradiol       Date:  2014-12-11       Impact factor: 3.825

Review 5.  Radiation necrosis: relevance with respect to treatment of primary and secondary brain tumors.

Authors:  James Fink; Donald Born; Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

Review 6.  Treatment-related changes in glioblastoma: a review on the controversies in response assessment criteria and the concepts of true progression, pseudoprogression, pseudoresponse and radionecrosis.

Authors:  P D Delgado-López; E Riñones-Mena; E M Corrales-García
Journal:  Clin Transl Oncol       Date:  2017-12-07       Impact factor: 3.405

Review 7.  Liquid Biopsy Strategies to Distinguish Progression from Pseudoprogression and Radiation Necrosis in Glioblastomas.

Authors:  Anudeep Yekula; Koushik Muralidharan; Zachary S Rosh; Anna E Youngkin; Keiko M Kang; Leonora Balaj; Bob S Carter
Journal:  Adv Biosyst       Date:  2020-06-02

8.  Radionecrosis of the frontal lobe as a consequence of malignant ethmoid tumor management: incidence, diagnosis, risk factors, prevention and management.

Authors:  N Oker; P Lang; D Bresson; B George; J-P Guichard; M Wassef; E Sauvaget; S Froelich; R Kania; P Herman
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-16       Impact factor: 2.503

9.  Anticoagulation for radiation-induced neurotoxicity revisited.

Authors:  Caroline Happold; Ulrike Ernemann; Patrick Roth; Wolfgang Wick; Michael Weller; Friederike Schmidt
Journal:  J Neurooncol       Date:  2008-08-22       Impact factor: 4.130

10.  Anti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain.

Authors:  Xiaoyu Jiang; John A Engelbach; Liya Yuan; Jeremy Cates; Feng Gao; Robert E Drzymala; Dennis E Hallahan; Keith M Rich; Robert E Schmidt; Joseph J H Ackerman; Joel R Garbow
Journal:  Clin Cancer Res       Date:  2014-03-19       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.